Akari Therapeutics to Present at the 29th Annual ROTH Conference

NEW YORK and LONDON, March 7th, 2017

Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the 29th Annual ROTH Conference on March 14th, 2017, in Dana Point, California. The company is scheduled to present at 8:00 a.m. PST.

Click here to see full release